<DOC>
	<DOCNO>NCT02201251</DOCNO>
	<brief_summary>The purpose study evaluate safety topiramate monotherapy compare levetiracetam another standard antiepileptic drug ( AED ) , monotherapy new-onset recent-onset epilepsy ( seizure disorder ) pediatric growth maturation , bone mineralization , kidney stone formation child age 2 15 year .</brief_summary>
	<brief_title>A Study Investigate Safety Drugs Topiramate Levetiracetam Treating Children Recently Diagnosed With Epilepsy</brief_title>
	<detailed_description>This randomize ( study medication assign participant chance ) , open-label , multi-centric ( conducted one center ) 2-arm flexible-dose monotherapy study topiramate compare 1 another AED ( levetiracetam ) pediatric participant epilepsy . The total study duration 1 year 2 month per participant . The study consist 3 part : Screening ( , 28 day study commences Day 1 ) ; Treatment ( 1 year ) post-treatment ( 30 day ) . Safety primarily evaluate percentage participant kidney stone change baseline bone mineral density Month 12 .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Participant clinical diagnosis newonset recentonset epilepsy characterize partialonset seizure ( POS ) ( without secondary generalization ) primary generalize tonicclonic seizure ( PGTCS ) accordance criterion International League Against Epilepsy . The epilepsy diagnosis must within previous 2 year screen Caregivers ( parent legally acceptable representative ) participant must able accurately maintain participant takehome record seizure diary At screening , participant must weight height value within 5th 95th percentile chronological age ( base standard Child Height Weight Charts Centers Disease Control [ CDC ] ) Participant must never treat epilepsy ( treatmentna√Øve ) treat 1 standard antiepileptic drug ( AED ) temporary urgent AED use necessary . Previous AED exposure must exceed either follow : 1 . ) Thirtyone day immediately precede enrollment , 2 . ) A total 6 month previous AED exposure past AED discontinue least 1 year prior enrollment Parents ( legally acceptable representative ) participant must sign informed consent/permission document , indicate understand purpose procedure require study willing give permission child participate study . Participant 7 year age old , capable understanding nature study , must provide assent participation Participant surgically implant function vagus nerve stimulator Participant history seizure result correctable medical condition , metabolic disturbance , toxic exposure , neoplasm , active infection within 2 week prior first day Screening Participant uncontrolled seizure previously take either topiramate levetiracetam Participant history nonepileptic seizure within 2 week prior first day Screening Participant myoclonic absence seizure</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Pediatric</keyword>
</DOC>